Form 4 for XYL Xylem Inc.

Accepted 2021-12-02 00:00:00 ET · period of report 2021-12-01 · accession 0001209191-21-067548 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2021-12-02	2021-12-01	XYL	Pine Matthew Francis	SVP	S - Sale+OE	$121.32	-2,000	37.2K	-5%	-$242.6K
D	2021-12-02	2021-12-01	XYL	Pine Matthew Francis	SVP	M - OptEx	$63.55	+2,000	39.2K	+5%	+$127.1K
D	2021-12-02	2021-12-01	XYL	Pine Matthew Francis	SVP	M - OptEx	$0.00	-2,000	40.4K	-5%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-12-01	S	D	2,000	$121.32	37,217	D	—	—	(F1) The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on March 15, 2021. (F2) This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 441 Shares were sold at a range of prices from $118.56 to $119.23. 200 Shares were sold at a range of prices from $119.66 to $120.37. 400 Shares were sold at a range of prices from $120.94 to $121.61. 601 Shares were sold at a range of prices from $121.94 to $122.79. 358 Shares were sold at a range of prices from $122.97 to $123.27. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
2	Common	Common Stock	2021-12-01	M	A	2,000	$63.55	39,217	D	—	—
3	Derivative	Stock Option (Right to Buy)	2021-12-01	M	D	2,000	$0.00	40,423	D	$63.55 · — to 2030-05-07	2,000 Common	(F3) The May 7, 2020 option grant vests in one third increments on May 7, 2021, May 7, 2022 and May 7, 2023.